This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 Stocks in the Limelight on Stellar Relative Price Strength
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Herbalife (HLF) in Focus: Stock Moves 5.2% Higher
by Zacks Equity Research
Herbalife (HLF) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Rite Aid's (RAD) Q4 Loss Wider Than Expected, Sales Rise Y/Y
by Zacks Equity Research
Strong revenues at pharmacy services and retail pharmacy segments aided Rite Aid's (RAD) Q4 results. Further, management issued FY21 view, which reflects no COVID-19 impacts.
Pharmacies & Drug Stores Industry Outlook: Prospects Mixed
by Urmimala Biswas
The Retail - Pharmacies and Drug Stores industry is known for heavy consolidations.
Rite Aid (RAD) Earnings Surpass Estimates in Q3, Stock Up
by Zacks Equity Research
Rite Aid (RAD) posts robust results in third-quarter fiscal 2020. Notably, the bottom line benefits from higher adjusted EBITDA in the quarter.
Rite Aid (RAD) Beats Q2 Earnings Estimates, Updates View
by Zacks Equity Research
Rite Aid (RAD) posts mixed second-quarter fiscal 2020 results. Further, management revises its view for the fiscal year.
Analysts Estimate Herbalife (HLF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Herbalife (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rite Aid Expands in Northeast With Thrifty Ice Cream Brand
by Zacks Equity Research
Rite Aid (RAD) expands the availability of its Thrifty Ice Cream brand in select stores in Delaware, New York, Maryland, New Jersey and Pennsylvania.
Rite Aid (RAD) Incurs Loss in Q1, Revenues Decline Y/Y
by Zacks Equity Research
Rite Aid (RAD) incurs loss in first-quarter fiscal 2020. However, it reaffirms outlook for the fiscal year.
Herbalife (HLF) Jumps: Stock Rises 5.7%
by Zacks Equity Research
Herbalife (HLF) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Herbalife (HLF) Q1 Earnings Miss Estimates, Stock Down 4%
by Zacks Equity Research
Herbalife Nutrition (HLF) posts dismal results in first-quarter 2019. Also, the company provides view for the second quarter and lowers its guidance for 2019.
Herbalife Nutrition (HLF) Beats on Q4 Earnings, Sales Up Y/Y
by Zacks Equity Research
Herbalife Nutrition's (HLF) Q4 results gain on volume growth across most regions. However, higher expenses are a drag.
Analysts Estimate Herbalife (HLF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Herbalife (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors to Know Ahead of Herbalife's (HLF) Q4 Earnings
by Zacks Equity Research
Herbalife (HLF) is likely to gain from its direct-selling network, product portfolio and solid volumes. However, unfavorable currency movements and stiff competition may hurt the bottom line.
Herbalife (HLF) Volume Growth Solid, Currency Woes Linger
by Zacks Equity Research
Herbalife (HLF) exhibits consistent growth in volume points across key markets. However, adverse currency impacts are expected to dent 2018's performance.
Should Invesco Russell 1000 Equal Weight ETF (EQAL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EQAL
Herbalife Unveils Preliminary Volume Points Data & CEO Exit
by Zacks Equity Research
Herbalife Nutrition (HLF) reveals Johnson's immediate appointment as an interim CEO after Richard Goudis' exit. Also, the company unveils preliminary volume points data for Q4.
Pharmacies & Drug Stores Industry Outlook: Prospects Look Weak
by Zacks Equity Research
Pharmacy retailers are gradually realizing the growing market demand for Medicare plan options. This apart, they are aggressively emphasizing on chronic disease care and management.
Will Volume Growth Continue Aiding Herbalife (HLF) in 2019?
by Zacks Equity Research
Herbalife (HLF) gains from continued rise in volume points and a strong global presence.
Zacks.com highlights: Herbalife Nutrition, Arch Coal, Crocs, Attunity and Cadence Design Systems
by Zacks Equity Research
Zacks.com highlights: Herbalife Nutrition, Arch Coal, Crocs, Attunity and Cadence Design Systems
Herbalife (HLF) Up 3.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Herbalife (HLF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bet on These 5 Top-Ranked Liquid Stocks for Stellar Returns
by Zacks Equity Research
Here are five top-ranked liquid stocks that can make a winning portfolio for investors.
Zacks.com featured highlights include: Herbalife, Crocs, Attunity and Cadence Design
by Zacks Equity Research
Zacks.com featured highlights include: Herbalife, Crocs, Attunity and Cadence Design
4 Top-Ranked Liquid Stocks for Impressive Returns
by Zacks Equity Research
Here are four top-ranked liquid stocks that investors can count on for stellar returns.
US Stocks Enjoy Highest Post-Midterm Gains Since 1982: 5 Picks
by Swarup Gupta
A large swathe of market watchers thinks that a gridlocked Congress will be beneficial for U.S. equity markets.